{
    "clinical_study": {
        "@rank": "35015", 
        "arm_group": [
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Placebo"
            }, 
            {
                "arm_group_label": "Dexmedetomidine", 
                "arm_group_type": "Experimental", 
                "description": "Dexmedetomidine intravenous infusion during scan."
            }, 
            {
                "arm_group_label": "Propofol", 
                "arm_group_type": "Experimental", 
                "description": "Propofol intravenous infusion during scan."
            }, 
            {
                "arm_group_label": "Ketamine", 
                "arm_group_type": "Experimental", 
                "description": "Ketamine intravenous infusion during scan."
            }, 
            {
                "arm_group_label": "Nitrous Oxide", 
                "arm_group_type": "Experimental", 
                "description": "Nitrous Oxide inhalation during scan."
            }
        ], 
        "brief_summary": {
            "textblock": "This preclinical phase 1 development study in healthy volunteers seeks to identify if low\n      doses of commonly used non-triggering anesthetic agents might have clinical utility for\n      modulating emotional memory processing and to understand the nature of the brain mechanisms\n      of drug action.  Optimally, a drug, dose and brain mechanism of action will be identified\n      that will form the foundation for future use in clinical studies of patients with PTSD."
        }, 
        "brief_title": "Developing Anesthesia as Post Traumatic Stress Disorder (PTSD) Therapy", 
        "completion_date": {
            "#text": "April 2013", 
            "@type": "Anticipated"
        }, 
        "condition": "Healthy", 
        "condition_browse": {
            "mesh_term": [
                "Stress Disorders, Post-Traumatic", 
                "Stress Disorders, Traumatic"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Healthy adults.\n\n          -  Between the ages of 18 and 35.\n\n        Exclusion Criteria:\n\n          -  Pregnancy.\n\n          -  Left-handed.\n\n          -  Unusual facial anatomy.\n\n          -  History of esophageal reflux.\n\n          -  Respiratory problems.\n\n          -  Central nervous system disorders.\n\n          -  Cardiovascular problems.\n\n          -  Kidney disease.\n\n          -  Diabetes.\n\n          -  History of Substance abuse.\n\n          -  History of adverse anesthetic reactions.\n\n          -  Hepatitis.\n\n          -  Failure to pass MRI screening questionnaire.\n\n          -  Fear of small-enclosed spaces.\n\n          -  Mental illness.\n\n          -  Non-native English speakers."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "35 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "315", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 16, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01736020", 
            "org_study_id": "MIRB 1007, UCI 2004-3707", 
            "secondary_id": "R34MH087390"
        }, 
        "intervention": [
            {
                "arm_group_label": "Dexmedetomidine", 
                "description": "A low dose of dexmedetomidine is used during scanning after dose piloting outside the scanner for memory effects and tolerability.", 
                "intervention_name": "Dexmedetomidine", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Propofol", 
                "description": "A low dose of propofol is used during scanning after dose piloting outside the scanner for memory effects and tolerability.", 
                "intervention_name": "Propofol", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Ketamine", 
                "description": "A low dose of ketamine is used during scanning after dose piloting outside the scanner for memory effects and tolerability.", 
                "intervention_name": "Ketamine", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Nitrous Oxide", 
                "description": "A low dose of nitrous oxide is used during scanning after dose piloting outside the scanner for memory effects and tolerability.", 
                "intervention_name": "Nitrous Oxide", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Anesthetics", 
                "Ketamine", 
                "Nitrous Oxide", 
                "Propofol", 
                "Dexmedetomidine"
            ]
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "November 27, 2012", 
        "location": {
            "facility": {
                "address": {
                    "city": "Irvine", 
                    "country": "United States", 
                    "state": "California", 
                    "zip": "92697"
                }, 
                "name": "University of California, Irvine"
            }, 
            "investigator": {
                "last_name": "Michael T Alkire, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "5", 
        "official_title": "Developing Anesthesia as PTSD Therapy", 
        "other_outcome": {
            "description": "Subjective and objective measures of subject responses to the various agents are noted.", 
            "measure": "Tolerability", 
            "safety_issue": "Yes", 
            "time_frame": "Baseline"
        }, 
        "overall_contact": {
            "email": "malkire@uci.edu", 
            "last_name": "Michael T Alkire, MD", 
            "phone": "949 824 6128"
        }, 
        "overall_contact_backup": {
            "email": "hhayama@gmail.com", 
            "last_name": "Hiroki Hayama, PhD", 
            "phone": "949 824 6128"
        }, 
        "overall_official": {
            "affiliation": "University of California, Irvine and Long Beach VA Medical Center", 
            "last_name": "Michael T Alkire, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 1", 
        "primary_completion_date": {
            "#text": "April 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "The proportion of items remembered in long-term memory 4 days after viewing emotional or neutral pictures.", 
            "measure": "Number of events remembered", 
            "safety_issue": "No", 
            "time_frame": "Day 4"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01736020"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Southern California Institute for Research and Education", 
            "investigator_full_name": "Michael Alkire", 
            "investigator_title": "Associate Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "Evoked fMRI responses to emotional and neutral pictures are measured and later correlated with subsequent memory performance.", 
            "measure": "Event-related fMRI BOLD signals", 
            "safety_issue": "No", 
            "time_frame": "Baseline"
        }, 
        "source": "Southern California Institute for Research and Education", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "National Institute of Mental Health (NIMH)", 
                    "agency_class": "NIH"
                }, 
                {
                    "agency": "University of California, Irvine", 
                    "agency_class": "Other"
                }
            ], 
            "lead_sponsor": {
                "agency": "Southern California Institute for Research and Education", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "September 2009", 
        "study_design": "Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Basic Science", 
        "study_type": "Interventional", 
        "verification_date": "November 2012"
    }
}